2Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994,264: 436-440.
3Gulley ML, Nicholls JM, Schneider BG,et al.Nasopharyngeal carcinoma frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. Am J Pathol,1998,152:865-869.
4Sobin LH.TNM classification of malignant tumors, International Union Against Cancer. 5th ed. New York:John Wiley Sons Inc, 1997.26.
5Shanmugaratnam K, Sobin LW. World Health Organization international histological classification: histological typing of tumors of the upper respiratory tract and ear.2nd ed. Berlin:Springer-Verlag,1991.
6Herman JG, Merlo A, Mao L, et al.Inactivation of the CDKN2/ p16/MTS1 gene is frenquently associated with aberrant DNA methylation in all common human cancer. Cancer Res,1995, 55:4525-4529.
7Cairns P, Mao L, Merlo A, et al. Rates of p16(MTS1) mutations in primary tumors with 9P loss. Science, 1994,265:415-417.
8Lo KW, Huang DP,Lau KM. p16 gene alterations in nasopharyngeal carcinoma. Cancer Res,1995,55:2039-2043.
9Lo KW,Cheung ST,Leung SF,et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res,1996, 56: 2721-2725.
